Free Trial
OTCMKTS:OXBDF

Oxford Biomedica (OXBDF) Stock Price, News & Analysis

Oxford Biomedica logo
$4.66 +0.73 (+18.68%)
As of 05/29/2025 12:39 PM Eastern

About Oxford Biomedica Stock (OTCMKTS:OXBDF)

Key Stats

Today's Range
$4.19
$4.66
50-Day Range
$3.15
$4.12
52-Week Range
$3.15
$5.68
Volume
550 shs
Average Volume
12,757 shs
Market Capitalization
$493.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, and adenoviral vectors. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Receive OXBDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter.

OXBDF Stock News Headlines

Oxford BioMedica (OXBDF) Receives a Buy from RBC Capital
“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
When Will Oxford Biomedica plc (LON:OXB) Turn A Profit?
See More Headlines

OXBDF Stock Analysis - Frequently Asked Questions

Oxford Biomedica's stock was trading at $5.3950 on January 1st, 2025. Since then, OXBDF stock has decreased by 13.6% and is now trading at $4.66.
View the best growth stocks for 2025 here
.

Shares of OXBDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:OXBDF
Previous Symbol
NASDAQ:OXBDF
CIK
N/A
Fax
N/A
Employees
891
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$111.34 million
Price / Cash Flow
N/A
Book Value
$1.01 per share
Price / Book
4.61

Miscellaneous

Free Float
N/A
Market Cap
$493.78 million
Optionable
Not Optionable
Beta
1.09
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:OXBDF) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners